© Fraunhofer IZI
EU project imSAVAR
Making novel therapeutics safer: Fraunhofer ITEM participates in an EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.